C4 Therapeutics (CCCC) Research & Development (2019 - 2026)

C4 Therapeutics' Research & Development history runs 8 years deep, the most recent figure standing at $24.6 million for Q1 2026.

• In Q1 2026, Research & Development fell 9.11% year-over-year to $24.6 million; the TTM figure through Mar 2026 stood at $101.8 million (down 11.64% YoY), while the FY2025 annual figure was $104.2 million, down 5.78% from the prior year.
• Research & Development was $24.6 million for Q1 2026 at C4 Therapeutics, down from $25.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $32.5 million in Q4 2024 to a low of $22.5 million in Q1 2024.
• Historically, Research & Development has averaged $27.9 million across 5 years, with a median of $28.3 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Research & Development jumped 34.51% in 2022, then retreated 23.16% in 2025.
• A 5-year view of Research & Development shows it stood at $30.7 million in 2022, then fell by 0.85% to $30.4 million in 2023, then increased by 6.98% to $32.5 million in 2024, then declined by 23.16% to $25.0 million in 2025, then slipped by 1.51% to $24.6 million in 2026.
• The last three Research & Development figures came in at $24.6 million (Q1 2026), $25.0 million (Q4 2025), and $26.0 million (Q3 2025), per Business Quant data.